Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2015 Feb 20;215:52–55. doi: 10.1016/j.jviromet.2015.02.012

Diagnostic performance of a rapid in-clinic test for the detection of Canine Parvovirus under different storage conditions and vaccination status

Maria C Kantere a, Labrini V Athanasiou b,, Vassiliki Spyrou c, Constantinos S Kyriakis d, Vassilios Kontos e, Dimitrios C Chatzopoulos a, Constantina N Tsokana a, Charalambos Billinis a
PMCID: PMC7119840  PMID: 25707551

Highlights

  • Quick laboratory confirmation of parvoenteritis is important to start treatment.

  • In-clinic tests are quick and simple in use.

  • A positive rapid test result almost certainly indicates the presence of the virus.

  • Vaccination status and storage condition affects the results of the in-clinic test.

Keywords: Canine parvovirus, Method comparison, Rapid in-clinic diagnostic test

Abstract

Canine parvovirus (CPV) is one of the most common causes of acute haemorrhagic enteritis in young dogs, while clinical diagnosis is often indecisive. The aim of our study was to evaluate the diagnostic accuracy of an in-clinic rapid test in the detection of CPV infection in dogs. To this end, we compared the Rapid Diagnostic Kit of Canine Parvovirus, Coronavirus and Rotavirus antigen (Quicking®) to PCR, which is considered as the most reliable diagnostic method. A total of 78 duplicated faecal samples were collected from diarrhoeic dogs. Vaccination history within a month prior to the onset of diarrhoea was reported for 12 of the sampled dogs. The rapid diagnostic test was performed in 23 of the faecal samples directly, while the rest were placed into a sterile cotton tipped swab suitable for collection and transportation of viruses (Sigma Σ-VCM®) and stored at −20 °C. The sensitivity of the Quicking rapid diagnostic test compared to PCR in the total number of samples, in samples from non-vaccinated dogs and in samples tested directly after collection were 22.22% (95% CI: 13.27–33.57%), 26.67% (95% CI: 16.08–39.66%) and 76.47% (95% CI: 50.10–93.04%) respectively, while the specificity of the test was 100% in any case. In conclusion, negative results do not exclude parvoenteritis from the differential diagnosis, especially in dogs with early vaccination history, but a positive result almost certainly indicates CPV infection. An improved sensitivity may be expected when the test is performed immediately.


Canine parvovirus (CPV) of the family Parvoviridae is one of the main enteric pathogens in dogs, especially puppies between 4 and 12 weeks old. CPV-2 is a small, non-enveloped icosahedral single-stranded DNA virus (Strassheim et al., 1994), related to other parvoviruses that infect carnivores, such as Feline Panleukopenia Virus (FPLV), Mink Enteritis Virus (MEV) and Racoon Parvovirus (RPV). CPV 2 has undergone mutations, resulting in recognition of subtypes 2a and 2b, while a new strain has also been detected in Italy (Martella et al., 2004). This variant (CPV-2c) now co-circulates with other CPV types in Vietnam (Nakamura et al., 2004), Spain (Decaro et al., 2006), Germany, France (Decaro et al., 2011), Portugal (João Vieira et al., 2008), USA (Gates et al., 2014, Hong et al., 2007), Brazil (Pinto et al., 2012) and Greece (Ntafis et al., 2010).

The gastroenteric-associated lymphoid tissues and intestinal crypts represent the target tissues for viral replication of CPV. This results in haemorrhagic diarrhoea, the most characteristic form of clinical disease. Its duration and severity strongly correlate to the titres of maternally derived antibodies at the time of infection. Virus is transmitted via the faecal-oral route through contact with faeces, soil or fomites that carry the virus. It is shed in the faeces of infected dogs within 4–5 days from exposure, throughout the period of clinical disease, and for up to ten days after recovery (Decaro et al., 2005b).

Clinical diagnosis of enteritis induced by CPV-2 is difficult and often indefinite. Therefore, it should be rapidly confirmed by reliable laboratory methods in order to begin therapeutic efforts as soon as possible. Rapid, in-clinic immunochromatographic assays are available for the diagnosis of CPV infection (Schmitz et al., 2009). Apart from that, faeces from clinically ill dogs can be tested using haemagglutination, virus isolation (Desario et al., 2005) and molecular methods (PCR or Real Time PCR) (Decaro et al., 2005a). However, in-clinic tests are still the most frequently used diagnostic tool in everyday veterinary practice, as the procedure is simple, inexpensive and timely.

The aim of the present study is to evaluate the diagnostic accuracy of Rapid Diagnostic Kit of Canine Parvovirus, Coronavirus and Rotavirus antigen (Quicking®) in the detection of CPV infection in dogs compared to PCR, which is considered as the most reliable diagnostic method. The diagnostic performance of this commercial rapid test was also assessed after examining samples under different storage conditions and samples collected from animals with different vaccination status.

A total number of 78 duplicated samples were collected from dogs with symptoms compatible with parvoenteritis, such as: lethargy, loss of appetite, fever, vomiting, haemorrhagic small-bowel diarrhoea, and dehydration. Specimens were collected following clinical examination and detailed recording of the medical and vaccination history of each animal. In 23 of the faecal samples, the Quicking Rapid Test was performed immediately after sample collection according to the manufacturer's instructions. The rest of the samples were placed into a sterile cotton tipped swab suitable for collection and transportation of viruses (Sigma Σ-VCM) and they were stored at −20 °C pending analysis. All samples were examined both with the Quicking Rapid Test and by PCR. The tests were conducted independently and the readers of PCR were blinded for the result of the other method.

The Quicking Rapid Test is a combined cassette used to differentially diagnose the presence of antigens from the three enteric viruses. The test is based on a sandwich lateral flow immunochromatographic assay. A visible T band in the corresponding testing window denotes the presence of any of the three pathogens in the sample. Regardless of the collection method, the wet swab was inserted in the included buffer tube and was stirred to ensure good sample extraction, as per manufacturer's instructions. Afterwards, three drops were placed in the sample holes of the cassette of the kit. The results were read within 5–10 min and were classified as positive or negative. No invalid results were observed.

To extract the viral DNA, the faecal specimens were homogenized in phosphate buffered saline (PBS) at a percentage of 10% w/v. After a brief centrifugation at high speed, 200 μL of the supernatant of each specimen were used for nucleic acid purification. The aliquots were incubated at 65 °C for 10 min to inactivate PCR inhibitors and then they were chilled on ice (Uwatoko et al., 1995). A commercial DNA Purification kit (Thermoscientific Genomic DNA Purification Kit) was used to complete extraction from the specimens according to the manufacturer's protocol.

Conventional PCR was performed using the primer pair Hfor/Hrev that amplifies a fragment of the capsid protein-encoding gene CPV-2 according to Decaro et al. (2005a) with slight modifications. These primers yield a product of 630 base pairs. Each 50 μL reaction mixture contained PCR buffer 1× (KCl 50 mM, Tris–HCl 10 mM, pH 8.3), MgCl2 2 mM, 200 mM of each deoxynucleotide, 1 μM of each primer, 2 U of DNA Polymerase (Thermoscientific Maxima Hot Start Taq DNA polymerase) and 10 mL of template DNA. The thermal conditions of this protocol initially indicate an activation of Hot Start Taq DNA polymerase at 94 °C for10 min. Following this step, 40 cycles of denaturation at 94 °C for 30 s, annealing at 50 °C for 1 min and polymerization at 72 °C for 1 min, and finally an extension at 72 °C for 10 min. Following PCR, electrophoresis was performed using 8 μL of the PCR products in a 2% Tris acetate–EDTA–agarose gel. Product sizes were determined using a 100 bp molecular weight ladder.

The sensitivity, specificity and negative likelihood ratio (NLR) as well as the significance of the differences between sensitivities obtained among groups were calculated using commercial software (Calc v. 12.3.0.0 – MedCalc Software, Ostend, Belgium). Also the Kappa statistic was estimated to determine the agreement between the two methods. Kappa value of 1 indicates absolute agreement, whereas a value of 0 indicates that agreement occurs due to chance agreement. In general, Kappa values higher than 0.6 indicate a good level of agreement. In this study, k-values were calculated using commercial software (Graph Pad Prism v.6-Graph Pad Inc., San Diego, CA).

The results of both methods used per group are analytically presented in Table 1 . All samples were also negative for the other two pathogens of the rapid diagnostic test. The sensitivities and the NLR of the rapid diagnostic test in the total number of samples, in samples of non-vaccinated dogs and in samples tested directly after collection, are presented in Table 2 . The specificity of the test was 100% in any case. (95% CI: 0.69–0.88%). The Kappa value between the methods in the total number of samples, in different vaccination statuses and under different collection methods are presented in Table 3 .

Table 1.

Results of the immunochromatographic test and PCR per group tested.

Samples Immunochromatographic test
PCR
Positive Negative Positive Negative
Total of samples 16 62 72 6
Vaccinated animals 0 12 12 0
Unvaccinated animals 16 50 60 6
Directly examined 13 10 17 6

Table 2.

Sensitivity along with the negative likelihood ratio values for each separate group and comparison of proportions.

Samples SE 95% CI NLR 95% CI
Total of samples 22.22%a 13.27–33.57% 0.78 0.69–0.88
Vaccinated animals 0b
Unvaccinated animals 26.67%a 16.08–39.66% 0.73 0.63–0.85
Directly examined 76.47%c 50.1–93.04% 0.24 75.12–100%

a,b,c Figures with different superscripts differ significantly (P < 0.005).

Table 3.

The k-value estimation between the in-clinic assay (Quicking®) and the established PCR method as well as the strength of agreement corresponding to each calculation for the three groups.

Samples Agreement
k-Value Strength of agreement
Total number of samples 0.028 Poor
Unvaccinated animals 0.038 Poor
Samples examined directly 0.203 Fair

Canine Parvovirus still represents a major cause of morbidity and mortality in puppies, despite widespread vaccination. A rapid and definitive diagnosis of CPV-2 infection is crucial, especially in spaces overcrowded with dogs (kennels, shelters, veterinary hospitals) in order to isolate infected animals, start treatment and prevent further spread of the virus. Commercial in-clinic rapid tests are the only assays that allow a quick and low-cost diagnosis of CPV in faeces of dogs. According to recent studies, these test seem to also detect the most novel CPV-2c variant (Decaro et al., 2010, Markovich et al., 2012, Decaro et al., 2013).

Immunochromatographic assays are less sensitive compared to laboratory methods, as they require a significant quantity of viral antigen to produce a visible band. Additionally, the interpretation of the result depends on the subjectivity of the operator, especially when the virus quantity is low. Consequently, more sophisticated laboratory techniques should be used for the reliable diagnosis of parvoenteritis, such as haemagglutination (HA), virus isolation (VI) and the polymerase chain reaction. These techniques can only be carried out in specialized laboratories and by trained personnel.

Despite the short time required for the performance of the test (about 4 h), the HA assay is not frequently used because of the demand for fresh porcine erythrocytes (Desario et al., 2005). Additionally, some CPV strains do not have any haemagglutination activity (Parrish et al., 1988, Cavalli et al., 2001). On the other hand, virus isolation is time-consuming (requiring and incubation period of 5–10 days) and labour-intensive (demand for cell cultures, specialized staff, additional testing by HA). Although both methods are highly specific (Schmitz et al., 2009), they are characterized by low sensitivity probably due to the presence of high antibodies titres in the intestinal lumen which may bind to virions and lead to false negative results (Desario et al., 2005). Furthermore, they are less likely to detect CPV-2, during the late stage of the infection, when the amounts of the virus shed in faeces are significantly reduced.

It has been proved that molecular methods are more sensitive than traditional techniques, (Decaro et al., 2005a, Desario et al., 2005). The high sensitivity of PCR allows the detection of animals shedding CPV at low titres in the faeces. This can result in the timely introduction of measures for prophylaxis and prevention from epizootics in overcrowded spaces. Moreover, conventional PCR provides quick results, i.e., within 6 h (Decaro et al., 2005a). However, positive results that do not correspond to natural infection may occur due to vaccine-induced faecal shedding of the CPV. Modified live-virus vaccinations are very common and CPV vaccine persistence in the organism has not been studied thoroughly. Since, no gold standard has been established for the detection of CPV in faeces and PCR is the most sensitive assay, it serves as the reference method in the present study (Schmitz et al., 2009).

In our study, we compare the results between the Quicking Rapid Test and conventional PCR, in the total number of the samples, in vaccinated animals and in samples tested immediately after collection. It was demonstrated, by calculating the k-value, that there is poor agreement between the two laboratory methods when the total number of samples and non-vaccinated animals were examined. Nevertheless, it was found that there is fair agreement between the in-clinic assay and the reference method, when the samples were tested directly after the collection.

Sensitivity and specificity results suggest that a positive result almost certainly indicates the presence of the virus but negative results do not rule out the possibility of CPV infection. As it has been reported in previous studies, the most likely explanation for the low sensitivity of the immunochromatographic assay compared to PCR is the sequestration of viral particles by gut antibodies mainly during late stages of infection (Desario et al., 2005, Decaro et al., 2005b). Furthermore, the fact that all vaccinated animals were negative in the immunochromatographic assay and positive in PCR, could be attributed to the low vaccine viral loads that were detected by PCR but not by the in-clinic test (Desario et al., 2005). The possible presence of the new CPV-2c variant does not account for the low sensitivity of the rapid test, as previous studies have shown that CPV-2c is detected by similar immunochromatographic assays (Decaro et al., 2010).

Other statistical methods commonly used for the evaluation of diagnostic methods are positive and negative predictive values that are influenced by the prevalence of disease. Since an accurate estimation of disease prevalence is rather challenging to be made, the two above-mentioned values were omitted. Instead, Negative Likelihood Ratio (NLR) was chosen, as it does not depend on disease prevalence. In fact, a good performance of the method is demonstrated when NLR value is <0.1, while NLR >0.5 suggests a poor performance. For the total number of samples, as well as for the samples of unvaccinated animals, NLR was high, but it was adequately low for the immediately tested samples. The denominator of the equation estimating the Positive Likelihood Ratio (PLR) is zero due to 100% specificity of the assay, which makes the calculation of this value impossible.

In conclusion, the Quicking Rapid Test was evaluated as an extremely specific method but a poorly sensitive one in comparison to PCR. This fact leads us to comment that negative results do not exclude parvoenteritis from the differential diagnosis, but a positive result almost certainly indicates CPV infection. Furthermore, the in-clinic immunochromatographic assay's sensitivity is increased when the samples are examined immediately after collection. This study confirms the findings of a previous research, which demonstrated that a similar assay produced negative results on faecal samples from vaccinated animals (Decaro et al., 2014). Consequently, the Rapid Diagnostic Kit of Canine Parvovirus, Coronavirus and Rotavirus antigen (Quicking®) can be used for early diagnosis of parvoenteritis, to exclude the presence of the pathogen, but in questionable cases, faecal samples should be sent for further laboratory investigation. Apart from that, veterinary practitioners should always keep in mind that a correct diagnosis is based on a combination of history, clinical signs, biochemical parameters and positive faecal results. As CPV continues to be a serious lethal threat to puppies worldwide, additional research is required to further facilitate the etiological diagnosis of parvoenteritis.

Conflict of interest

None of the authors of this article has any financial or personal relationship with other people or Organizations that could inappropriately alter or bias the content of this work.

Acknowledgements

The study has been partially co-financed by the European Union (European Social Fund-ESF) and Greek national funds through the Operational Program “Education and Lifelong Learning” of the National Strategic Reference Framework (NSRF) – Research Funding Program: Thales. Investing in knowledge society through the European Social Fund.

References

  1. Cavalli A., Bozzo G., Decaro N., Tinelli A., Aliberti A., Buonavoglia D. Characterization of a canine parvovirus strain isolated from an adult dog. New Microbiol. 2001;24:239–242. [PubMed] [Google Scholar]
  2. Decaro N., Elia G., Martella V., Desario C., Campolo M., Trani L.D., Tarsitano E., Tempesta M., Buonavoglia C. A real-time PCR assay for rapid detection and quantitation of canine parvovirus type 2 in the feces of dogs. Vet. Microbiol. 2005;105:19–28. doi: 10.1016/j.vetmic.2004.09.018. [DOI] [PubMed] [Google Scholar]
  3. Decaro N., Desario C., Campolo M., Elia G., Martella V., Ricci D., Lorusso E., Buonavoglia C. Clinical and virological findings in pups naturally infected by canine parvovirus type 2 Glu-426 mutant. J. Vet. Diagn. Invest. 2005;17:133–138. doi: 10.1177/104063870501700206. [DOI] [PubMed] [Google Scholar]
  4. Decaro N., Martella V., Desario C., Bellacicco A.L., Camero M., Manna L., d’Aloja D., Buonavoglia C. First detection of canine parvovirus type 2c in pups with haemorrhagic enteritis in Spain. J. Vet. Med. B: Infect. Dis. Vet. Public Health. 2006;53:468–472. doi: 10.1111/j.1439-0450.2006.00974.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Decaro N., Desario C., Beall M.J., Cavalli A., Campolo M., Dimarco A.A., Amorisco F., Colaianni M.L., Buonavoglia C. Detection of canine parvovirus type 2c by a commercially available in-house rapid test. Vet. J. 2010;184:373–375. doi: 10.1016/j.tvjl.2009.04.006. [DOI] [PubMed] [Google Scholar]
  6. Decaro N., Desario C., Billi M., Mari V., Elia G., Cavalli A., Martella V., Buonavoglia C. Western European epidemiological survey for parvovirus and coronavirus infections in dogs. Vet. J. 2011;187:195–199. doi: 10.1016/j.tvjl.2009.10.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Decaro N., Desario C., Billi M., Lorusso E., Colaianni M.L., Colao V., Elia G., Ventrella G., Kusi I., Bo S., Buonavoglia C. Evaluation of an in-clinic assay for the diagnosis of canine parvovirus. Vet. J. 2013;198:504–507. doi: 10.1016/j.tvjl.2013.08.032. [DOI] [PubMed] [Google Scholar]
  8. Decaro N., Crescenzo G., Desario C., Cavalli A., Losurdo M., Colaianni M.L., Ventrella G., Rizzi S., Aulicino S., Lucente M.S., Buonavoglia C. Long-term viremia and fecal shedding in pups after modified-live canine parvovirus vaccination. Vaccine. 2014;32:3850–3853. doi: 10.1016/j.vaccine.2014.04.050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Desario C., Decaro N., Campolo M., Cavalli A., Cirone F., Elia G., Martella V., Lorusso E., Camero M., Buonavoglia C. Canine Parvovirus infection: which diagnostic test for virus? J. Virol. Methods. 2005;126:179–185. doi: 10.1016/j.jviromet.2005.02.006. [DOI] [PubMed] [Google Scholar]
  10. Gates M., Gerhold R.W., Wilkes R., Gulsby W.D., Maestas L., Rosypal A., Miller K.V., Miller D.L. Parasitology, virology, and serology of free-ranging coyotes (Canis Latrans) from Central Georgia, USA. J. Wild. Dis. 2014 doi: 10.7589/2013-10-283. (e-pub-ahead of print) [DOI] [PubMed] [Google Scholar]
  11. Hong C., Decaro N., Desario C., Tanner P., Pardo M.C., Sanchez S., Buonavoglia C., Saliki J.T. Occurrence of canine parvovirus type 2c in the United States. J. Vet. Diagn. Invest. 2007;19:535–539. doi: 10.1177/104063870701900512. [DOI] [PubMed] [Google Scholar]
  12. João Vieira M., Silva E., Oliveira J., Luísa Vieira A., Decaro N., Desario C., Muller A., Carvalheira J., Buonavoglia C., Thompson G. Canine parvovirus 2c infection in central Portugal. J. Vet. Diagn. Invest. 2008;20:488–491. doi: 10.1177/104063870802000412. [DOI] [PubMed] [Google Scholar]
  13. Markovich J.E., Stucker K.M., Carr A.H., Harbison C.E., Scarlett J.M., Parrish C.R. Effects of canine parvovirus strain variations on diagnostic test results and clinical management of enteritis in dogs. J. Am. Vet. Med. Assoc. 2012;241:66–72. doi: 10.2460/javma.241.1.66. [DOI] [PubMed] [Google Scholar]
  14. Martella V., Cavalli A., Pratelli A., Bozzo G., Camero M., Buonavoglia D., Narcisi D., Tempesta M., Buonavoglia C. A canine parvovirus mutant is spreading in Italy. J. Clin. Microbiol. 2004;42:1333–1336. doi: 10.1128/JCM.42.3.1333-1336.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nakamura M., Tohya Y., Miyazawa T., Mochizuki M., Phung H.T., Nguyen N.H., Huynh L.M., Nguyen L.T., Nguyen P.N., Nguyen P.V., Nguyen N.P., Akashi H. A novel antigenic variant of Canine Parvovirus from a Vietnamese dog. Arch. Virol. 2004;149:2261–2269. doi: 10.1007/s00705-004-0367-y. [DOI] [PubMed] [Google Scholar]
  16. Ntafis V., Xylouri E., Kalli I., Desario C., Mari V., Decaro N., Buonavoglia C. Characterization of Canine Parvovirus 2 variants circulating in Greece. J. Vet. Diagn. Invest. 2010;22:737–740. doi: 10.1177/104063871002200512. [DOI] [PubMed] [Google Scholar]
  17. Parrish C.R., Burtonboy G., Carmichael L.E. Characterization of a nonhemagglutinating mutant of canine parvovirus. Virology. 1988;163:230–232. doi: 10.1016/0042-6822(88)90255-3. [DOI] [PubMed] [Google Scholar]
  18. Pinto L.D., Streck A.F., Gonçalves K.R., Souza C.K., Corbellini Â.O., Corbellini L.G., Canal C.W. Typing of canine parvovirus strains circulating in Brazil between 2008 and 2010. Virus Res. 2012;165:29–33. doi: 10.1016/j.virusres.2012.01.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Schmitz S., Coenen C., König M., Thiel H.J., Neiger R. Comparison of three rapid commercial Canine parvovirus antigen detection tests with electron microscopy and polymerase chain reaction. J. Vet. Diagn. Invest. 2009;21:344–345. doi: 10.1177/104063870902100306. [DOI] [PubMed] [Google Scholar]
  20. Strassheim M.L., Gruenberg A., Veijalainem P., Sgro J.Y., Parrish C.R. Two dominant neutralizing antigenic determinants of canine parvovirus are found on the threefold spike of the virus capsid. Virology. 1994;198:175–184. doi: 10.1006/viro.1994.1020. [DOI] [PubMed] [Google Scholar]
  21. Uwatoko K., Sunairi M., Nakajima M., Yamaura K. Rapid method utilizing the polymerase chain reaction for detection of canine parvovirus in feces of diarrheic dogs. Vet. Microbiol. 1995;43:315–323. doi: 10.1016/0378-1135(94)00102-3. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virological Methods are provided here courtesy of Elsevier

RESOURCES